Kyle W. Gano
President, CEO & DirectorMr. Kyle W. Gano, Ph.D., is President, CEO and Director at Neurocrine Biosciences, Inc since October 11, 2024. He was Chief Business Development and Strategy Officer at Neurocrine Biosciences, Inc. since 2020 until October 11, 2024. He had been Chief Business Development Officer at Neurocrine Biosciences Inc. since 2011 until 2020. Mr. Gano is responsible for Business and Commercial Development activities at Neurocrine. He is responsible for all business and corporate development activities, including the management of ongoing collaborations with AbbVie, Mitsubishi Tanabe Pharma, BIAL, Nxera Pharma (formerly Sosei Heptares), Sanofi S.A., Takeda Pharmaceutical Company Limited, Voyager Therapeutics, Xenon Pharmaceuticals, Idorsia Pharmaceuticals Ltd. and Heptares Therapeutics Limited. He also led the acquisition of Diurnal Group Plc in 2021, expanding Neurocrine's presence to the United Kingdom and European Union. From 2001 to 2011 he held several positions of increasing responsibility at Neurocrine spanning Marketing Analytics to Business Development. He also played key leadership roles in the development of three FDA-approved medicines - INGREZZA? (valbenazine), ORILISSA? (elagolix) and ORIAHNN? (elagolix, estradiol and norethindrone). Dr. Gano serves on the Board of Directors of California Life Sciences (CLS). He received his B.S. in Chemistry from the University of Oregon, B.S. in Biochemistry from the University of Washington and his Ph.D. in Organic Chemistry and M.B.A. in Finance from the University of California, Los Angeles.
Positions
- Company NameNeurocrine Biosciences, Inc.Stock CodeNBIXPositionPresident, CEO & DirectorColleagues
- WHWilliam H. RastetterIndependent Chairman of the Board
- MCMatthew C. AbernethyChief Financial Officer
- JOJude OnyiaChief Scientific Officer
- ESEric S. BenevichChief Commercial Officer
- EWEiry Wyn RobertsChief Medical Officer
- RFRichard F. PopsIndependent Director
- LVLeslie V. NorwalkIndependent Director
- SSShalini SharpIndependent Director
